Title Category Credit Event date Cost
Health Care Ethics and Safety: A Quality Case for Consumer Engagement*
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • APA
  • CCMC - Ethics
  • CDR
$0.00 Building a culture of health and well-being for those we care for means promoting compassionate, high-quality, efficient and person-centered care. When individuals and their families believe that we place their well-being at the center of what we do, there is a greater likelihood that outcomes will improve. In acute care settings, this might mean greater treatment adherence, shorter lengths of stay and fewer medication errors. However, HCPs often experience significant compassion fatigue and may dismiss compassion as less important than other aspects of care.
Pharmacy Benefit Management Technician Certification Program: Module 1
  • Pharmacy benefit management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • Attendance
$25.00 The purpose of this three-part series is to promote learning about PBM. This series was designed for those interested in learning more about managed care pharmacy and PBM. Module 1 introduces PBM and general pharmacy knowledge; module 2 covers the Health Insurance Portability and Accountability Act (HIPAA), formularies, plan types and claim adjudication; and module 3 discusses prior authorizations, drug utilization reviews and various service levels.Learning objectivesAt the end of this educational activity, participants should be able to:
Pharmacy Benefit Management Technician Certification Program: Module 2
  • Pharmacy benefit management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • Attendance
$25.00 The purpose of this three-part series is to promote learning about PBM. This series was designed for those interested in learning more about managed care pharmacy and PBM. Module 1 introduces PBM and general pharmacy knowledge; module 2 covers the Health Insurance Portability and Accountability Act (HIPAA), formularies, plan types and claim adjudication; and module 3 discusses prior authorizations, drug utilization reviews and various service levels.Learning objectivesAt the end of this educational activity, participants should be able to:
Pharmacy Benefit Management Technician Certification Program: Module 3
  • Pharmacy benefit management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • Attendance
$25.00 The purpose of this three-part series is to promote learning about PBM. This series was designed for those interested in learning more about managed care pharmacy and PBM. Module 1 introduces PBM and general pharmacy knowledge; module 2 covers the Health Insurance Portability and Accountability Act (HIPAA), formularies, plan types and claim adjudication; and module 3 discusses prior authorizations, drug utilization reviews and various service levels.Learning objectivesAt the end of this educational activity, participants should be able to:
Preventive Cardiovascular Care: What is New
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Accumulating evidence has revealed that intestinal microbiota play an important role in human health and disease, including cardiovascular diseases. This activity will discuss the roles of gut microbiota and focus on gut microbes as a factor and therapeutic target in cardiovascular disease. In addition, the latest guidelines for prevention and treatment of co-morbid conditions associated with cardiovascular disease will be reviewed.Learning ObjectivesAt the end of this educational activity, participants should be able to:
Current and Future Applications of Gene Therapy for Various Disease States
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Gene therapy has been investigated as a potential intervention in a number of diseases and/or disorders, including chronic neuropathic pain, melanoma, cardiovascular disease and cancer. This activity will review the latest evidence-based practice guidelines surrounding gene therapies, as well as available safety and efficacy data surrounding its use in a variety of disease states.Learning ObjectivesAt the end of this educational activity, participants should be able to:
Medical Advances and Optimal Treatment Approaches for Inflammatory Bowel Disease
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 The Centers for Disease Control (CDC) estimate that 1 to 1.3 million people suffer from inflammatory bowel disease (IBD) in the United States. These patients often require long-term management involving steroids, maintenance therapy with immunomodulators and biologicals, and acute interventions. During this activity, factors affecting the risk and course of IBD and the most updated protocols and guidelines for diagnosing and treating IBD will be discussed. New therapies targeting the immune process that are revolutionizing the treatment of IBD will also be presented.
Chronic Pain Is a Disease, Not a Symptom of Disease
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 When pain becomes chronic, it is no longer merely a symptom, but a disease in itself. According to the National Health Interview Survey, an estimated 25.3 million adults in the United States suffer from chronic pain. This activity will focus on what is new in the management of chronic pain and in what ways this field is evolving. The importance of interprofessional strategies to integrate pharmaceutical and nonpharmaceutical treatment options for chronic pain will be addressed, as well as the importance of improving communication with patients about chronic pain diagnosis and treatment.
Closing the Gap in Health Equity
  • Wellness
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - Ethics
$0.00 In the United States, racial/ethnic minority, rural, and low-income populations continue to experience suboptimal access to and inequity of health care despite decades of recognition of health disparities and policy mandates to eliminate them. There are a number of disease states with recognized disparities and many health care interventions designed to achieve health equity fall short due to gaps in knowledge and translation.
Chronic Kidney Disease: Early and Effective Intervention and Evidence-based Guidelines for Optimal Management
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Chronic kidney disease (CKD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted. It is responsible for premature death and demands a high economic price from both the private and public sectors. The prevalence of CKD is increasing, and more than 50 percent of adults 30–64 years old are projected to develop CKD over their lifetimes.

Pages